Meta-Iodobenzylguanidine-131I (MIBG-131I) for therapeutic use, solution for injection

Czystość radionuklidowa: 

≥ 99.9%

Czystość radiochemiczna: 

≥ 92%


24 hours

Okres ważności: 

4 days from the manufacturing date (expiry date is stated on the label).

Warunki przechowywania: 

Store MIBG-131I in an original container at the temperature below [-15oC], in accordance with regulations for radiation safety.  Transport in dry ice.
Protect from light. After defrosting store below 25oC for up to 2 hours. Transport in dry ice.

Postać farmaceutyczna: 

Solution for injection.

Skład jakościowy i ilościowy substancji czynnych: 

Meta-Iodo[131I]benzylguanidine sulphate,   370 - 740 MBq/ml

Wykaz substancji pomocniczych: 

sodium metabisulphite
copper (II) sulphate pentahydrate
sodium acetate trihydrate
acetic acid
benzyl alcohol
sodium chloride
water for injection

Rodzaj i zawartość opakowania: 

The MIBG-131I solution is delivered in 10 ml glass vials, with a possibility of drawing multidoses in an aseptic way. The vials are capped with rubber stoppers and aluminum caps and placed inside a shielded lead container. The outer transport packaging is a metal tin  with styrofoam insert.
Every source is accompanied with a certificate of radioactivity.

Wskazania do stosowania: 

Meta-Iodobenzylguanidine-131I (MIBG-131I) is a radiopharmaceutical used in cancer therapy. It is used in treating disseminated, malignant, metastatic lesions, such as pheochromocytoma, paraganglioma, neuroblastoma, neuroendocrine tumors of gestroenteropancreatic tract, and sometimes medullary thyroid carcinoma.



Nasza siedziba